Dosing regimen for treating pku with a piperidine inhibitor of slc6a19 function
AssigneeJnana Therapeutics Inc.
InventorsJohn Peter Throup, Heather Smith Blanchette
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating phenylketonuria, comprising administering to a patient in need thereof an effective amount of the following compound: or a pharmaceutically acceptable salt thereof
Claims83
A method of treating or preventing a disease or disorder associated with a genetic defect in phenylalanine hydroxylase, comprising orally administering to a patient in need thereof an effective amount of the following compound, or a pharmaceutically acceptable salt thereof:
- wherein the compound is formulated as a tablet.
A method of treating or preventing a disease or disorder associated with a genetic defect in phenylalanine hydroxylase, comprising orally administering to a patient in need thereof an effective amount of the following compound, or a pharmaceutically acceptable salt thereof:
- wherein the compound is formulated as a suspension.
Dependencies are inferred from the claim text.